leisure time -WSS

leisure time

author：comprehensive 2025-10-01 15:40:14 - browse：12

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： ASCO: Palliative care found as helpful given virtually as in person

WSS

Pumping milk in bathrooms at health conferences is common

Change Healthcare can notify patients about the breach, HHS says

Ionis drug prevents swelling attacks due to hereditary angioedema

Medicare bonuses could stop drug shortages under Senate plan

ASCO: AstraZeneca says CAR

Inaction leaves children at risk from dangerous chemotherapy drug

focus

leisure time

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

Head of FDA's diagnostics center, who led through Covid, retires

Medical leaders decry Supreme Court decision on affirmative action

At ASCO, AstraZeneca reports strong data for breast cancer drug

Medicare details structure of new drug price negotiation program

How to increase colonoscopy rates? Looks like an AI can help

Novavax promises a turnaround & Lilly roils the obesity market

The inclusion problem at the heart of rehabilitation research

BioMarin wins approval for gene therapy to treat hemophilia A

Microsoft launches AI tool for clinical documentation through Epic

hotspot

Dog Aging Project founders on what lies ahead after losing funding

Let's speed up science by embracing open access publishing

Let's speed up science by embracing open access publishing

What causes osteoarthritis? Researchers study link to brain protein

Immunocompromised patients offer clues on chronic Covid

Medicare bonuses could stop drug shortages under Senate plan

leisure time

hotspot

hotspot

Wikipedia